Page 7 - High Acuity News Today

StockNews.com initiated coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a report published on Friday morning. The brokerage issued a buy rating on the health services provider’s stock. Several other brokerages have also recently weighed in on AMED. TD Cowen increased their price target on shares of Amedisys from $84.00 to $101.00 and […]

StockNews.com began coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a research note published on Friday. The firm issued a buy rating on the health services provider’s stock. Other equities analysts have also issued reports about the company. Truist Financial raised their target price on Amedisys from $97.00 to $101.00 in a report […]

StockNews.com started coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a research note published on Thursday. The brokerage issued a buy rating on the health services provider’s stock. Other research analysts also recently issued research reports about the stock. Credit Suisse Group downgraded shares of Amedisys from an outperform rating to a neutral […]

Amedisys (NASDAQ:AMED – Get Free Report) posted its quarterly earnings data on Wednesday. The health services provider reported $1.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.09 by $0.28, Briefing.com reports. Amedisys had a net margin of 5.02% and a return on equity of 14.35%. The firm had revenue of […]

Amedisys (NASDAQ:AMED – Get Free Report) will post its quarterly earnings results on Tuesday, July 25th. Amedisys (NASDAQ:AMED – Get Free Report) last issued its quarterly earnings results on Thursday, May 4th. The health services provider reported $1.00 earnings per share for the quarter, topping the consensus estimate of $0.86 by $0.14. Amedisys had a […]

Amedisys (NASDAQ:AMED – Get Free Report) will be releasing its earnings data on Tuesday, July 25th. Amedisys (NASDAQ:AMED – Get Free Report) last released its earnings results on Thursday, May 4th. The health services provider reported $1.00 earnings per share for the quarter, topping analysts’ consensus estimates of $0.86 by $0.14. Amedisys had a return […]

StockNews.com assumed coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a research report report published on Wednesday. The brokerage issued a buy rating on the health services provider’s stock. A number of other brokerages also recently commented on AMED. Benchmark downgraded Amedisys from a buy rating to a hold rating in a research […]

Amedisys, Inc. (NASDAQ:AMED – Get Free Report) has earned a consensus rating of “Hold” from the thirteen ratings firms that are presently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation, nine have assigned a hold recommendation and three have issued a buy recommendation on the company. The average […]

Equities researchers at StockNews.com began coverage on shares of Amedisys (NASDAQ:AMED – Get Free Report) in a research note issued to investors on Tuesday. The firm set a “buy” rating on the health services provider’s stock. AMED has been the topic of a number of other reports. Benchmark cut Amedisys from a “buy” rating to […]

Jefferies Financial Group downgraded shares of Amedisys (NASDAQ:AMED – Free Report) from a buy rating to a hold rating in a research report released on Thursday morning, FlyOnTheWall reports. A number of other equities analysts have also weighed in on the stock. Benchmark lowered shares of Amedisys from a buy rating to a hold rating […]